Aeglea BioTherapeutics - Stock Price History | AGLE

Historical daily share price chart and data for Aeglea BioTherapeutics since 2021 adjusted for splits. The latest closing stock price for Aeglea BioTherapeutics as of September 27, 2021 is 7.82.
  • The all-time high Aeglea BioTherapeutics stock closing price was 11.99 on April 08, 2016.
  • The Aeglea BioTherapeutics 52-week high stock price is 9.90, which is 26.6% above the current share price.
  • The Aeglea BioTherapeutics 52-week low stock price is 5.82, which is 25.6% below the current share price.
  • The average Aeglea BioTherapeutics stock price for the last 52 weeks is 7.55.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Aeglea BioTherapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 7.5331 7.7500 11.0350 3.5100 7.8700 3.01%
2019 7.7195 8.0400 9.4000 6.1000 7.6400 2.00%
2018 8.7409 5.3800 11.0000 5.0700 7.4900 38.45%
2017 4.9522 4.5700 8.0300 2.9100 5.4100 24.37%
2016 6.3295 9.7700 11.9900 3.9600 4.3500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.384B $0.004B
Aeglea BioTherapeutics, Inc. is a biotechnology company which is engaged in developing enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism and cancer. Its portfolio of products consists of AEB1102, AEB3103, AEB2109 and AEB4104 which are in different clinical trial phase. Aeglea BioTherapeutics, Inc. is based in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29